Skip to main content
Premium Trial:

Request an Annual Quote

Congenica Joins Portuguese Whole-Exome Sequencing Project

NEW YORK (GenomeWeb) – British clinical genomics interpretation software developer Congenica said today that it has inked a deal with Coimbra (Portugal) Paediatric Hospital to analyze whole-exome sequencing data. 

The children's hospital, part of the Coimbra Hospital and University Centre, is licensing Congenica's Sapientia software platform to produce diagnostic reports for CHUC's In2Genome project.

In2Genome, which launched July 1, is a €1.2 million ($1.4 million) effort to improve the diagnosis of rare diseases via population-wide genomic data. Hospital officials called In2Genome the first initiative by a Portuguese medical center to provide exome sequencing reports to its patients. 

"One of the main aims of In2Genome will be to set up a whole-exome sequencing analysis service at our leading public hospital center," Coimbra Paediatric Hospital medical geneticist Sérgio Sousa said in a statement. "Our first project is the study of a large cohort of patients with neurodevelopmental disorders, namely intellectual disability syndromes with the aim of developing faster precise diagnostics to better support patient’s health and lifestyle outcomes."

Digital health and precision medicine firm Coimbra Genomics already is providing technology to that end. In July, that Portuguese vendor said its Elsie software platform is helping with analysis of clinical cases at the medical genetics unit of Coimbra Hospital and Universitary Centre. 

As part of its support of In2Genome, Coimbra is adapting its platform for integration into the analysis of the exome data.

The Scan

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.